Group 1 - The core reason for the strengthening of the US dollar since March is the relatively smaller impact on the US economy amid the Middle East conflict, leading to a return of funds to dollar assets, but this is not indicative of a liquidity crisis [1] - The narrative of a "weak dollar" has ended, reversing the previous trend of funds flowing from dollar assets to physical and other financial assets due to the US-Iran conflict [1] - Recent trends indicate that the strength of the US dollar may be nearing its end, with a potential confirmation of price bottoms for physical and non-US assets [1] Group 2 - Since late February, the vitamin market in Europe and domestically has experienced significant price volatility due to escalating Middle East conflicts and energy cost pressures, with Vitamin A prices increasing by nearly 82% and Vitamin E by over 75% [2] - The pharmaceutical team at Zhongyou Securities notes that the market space for related products may see effective recovery due to the combination of reversed supply-demand dynamics and geopolitical catalysts [2] - The raw material drug sector is currently driven by a dual momentum of "fundamental turning point + price increase expectations," with limited new capital expenditure in the past three years and a significant recovery potential for specific products like sartans and statins [3]

Investment Rating - The report does not explicitly provide an investment rating for the chemical industry Core Insights - The geopolitical tensions, particularly between the US and Iran, have led to significant disruptions in the chemical supply chain, affecting various sectors including fertilizers and semiconductors [1][2] - The chemical market is experiencing price fluctuations due to supply chain vulnerabilities, with specific products like helium and fertilizers facing acute shortages [1][2] - The AI industry is facing challenges due to increased demand for computing power, leading to a surge in CPU prices and extended delivery times [1] - Major companies are actively expanding production capacities to meet rising demand, with significant investments in AI infrastructure [1] Summary by Sections Market Review - Brent crude oil averaged $105.45 per barrel, down 0.87% week-on-week, while WTI crude oil averaged $92.98 per barrel, down 3.22% [9] - The basic chemical sector outperformed the index with a 2.31% increase, while the petrochemical sector saw a slight decline of 0.10% [10] Recent Views from the Chemical Team - The tire industry is stabilizing with a slight increase in operating rates, while raw material prices are on the rise [23] - The dye market remains stable, with prices for disperse dyes holding steady and active dyes experiencing an increase due to strong cost support [25][27] - The carbon dioxide market is seeing limited price increases due to insufficient demand support [28] Key Events - Iran's response to the US ceasefire proposal has created uncertainty in the market, impacting supply chains [2] - The shutdown of major ammonia plants in Australia and India has exacerbated the fertilizer supply crisis [2] - A significant reduction in helium supply due to attacks on Qatari facilities poses a threat to the semiconductor industry [2] Price Movements - The price of titanium dioxide has increased by 5.1% due to rising costs and supply constraints [29] - The market for vitamin A and E has seen price fluctuations, with both experiencing upward trends followed by stabilization [30] Production and Supply Chain Insights - The report highlights the ongoing challenges in the supply chain, with many companies facing production delays and increased costs due to geopolitical tensions [1][2][23] - The report notes that companies are adjusting their pricing strategies in response to rising raw material costs and supply chain disruptions [29][30]

Investment Rating - The report maintains a "Buy" rating for the chemical industry, highlighting its resilience and potential for recovery in demand and pricing [4][8]. Core Insights - BASF's Zhanjiang integrated base has commenced full production, marking a significant milestone as China's first wholly foreign-owned project in the heavy chemical sector, with a focus on high-end materials and special chemicals [3]. - Titanium dioxide prices have seen three consecutive increases within a month, indicating strong market dynamics and potential profitability for producers [3]. - The domestic tire industry is showing strong competitive advantages, with recommended stocks including Sailun Tire, Senqcia, General Motors, and Linglong Tire [4]. - The consumer electronics sector is expected to gradually recover, benefiting upstream material companies, with key players identified in the display materials supply chain [4]. - The phosphate chemical sector is tightening due to environmental regulations and increasing demand from the new energy sector, with recommended stocks including Yuntianhua, Chuanheng, Xingfa Group, and Batian [5]. - The fluorochemical sector is poised for recovery, with high-end fluoropolymers and fine chemicals experiencing rapid growth, suggesting investment opportunities in leading companies [5]. Summary by Sections Chemical Sector Market Review - The overall performance of the chemical sector saw the CSI 300 index decline by 1.41%, while the CITIC Basic Chemical Index rose by 3.31% [14]. - The top-performing sub-industries included potassium fertilizer (up 11.58%) and other chemical raw materials (up 6.4%) [17]. Key Industry Dynamics - BASF's Zhanjiang base is designed to meet the growing market demand in China and the Asia-Pacific region, utilizing a fully renewable energy supply and advanced digital control systems [3]. - The price adjustments in titanium dioxide reflect a collective price increase trend among major producers, indicating strong market demand [3]. Investment Themes - The tire sector is highlighted for its growth potential, with domestic companies showing strong competitive positions [4]. - The consumer electronics recovery is expected to benefit upstream material suppliers, with specific companies recommended for investment [4]. - The phosphate and fluorochemical sectors are identified as having strong fundamentals, with specific companies recommended for investment based on their market positions and growth potential [5].

Core Viewpoint - The recent surge in vitamin prices is primarily driven by proactive supply contraction rather than geopolitical conflicts, indicating that the vitamin industry has entered the early stage of a cyclical recovery [6][32]. Group 1: Price Surge Dynamics - Since the outbreak of the Middle East conflict in late February, the vitamin market has experienced a strong price increase, particularly for Vitamin A and E, due to supply pressures in Europe [2][3]. - Vitamin A prices rose from 60.5 yuan/kg to 110 yuan/kg, an increase of 82%, while Vitamin E prices increased from 57.5 yuan/kg to 97.5 yuan/kg, a rise of 70% [2]. - The core reason for the price increase is not the geopolitical situation but rather a deliberate reduction in supply by major producers [6][14]. Group 2: Supply Chain and Market Structure - The vitamin industry is characterized by a high concentration of production, with major players like DSM and BASF dominating the market, which gives them significant pricing power [11][14]. - The largest application of vitamins is in animal feed, accounting for 80% of usage, with a low cost impact on feed, making downstream demand relatively insensitive to price changes [9][10]. - Following a previous price war, major producers have shifted strategies from market share competition to proactive supply contraction to restore profitability [14][15]. Group 3: Future Supply and Market Outlook - The potential for a rapid recovery in supply over the next 1-2 quarters is low due to several factors, including the time required for European production facilities to restart and the lengthy process of building new capacity [19][22]. - The proactive supply control strategies employed by producers are likely to continue in the short term, as many products remain unprofitable [23]. - The current low inventory levels and tight supply conditions are a direct result of these strategies, suggesting that the price increase may persist in the near term [16][32]. Group 4: Investment Opportunities - Companies with strong pricing power and solid earnings visibility, such as New Hope Liuhe and Zhejiang Medicine, are positioned well in the current market environment [27]. - The focus should be on firms that can benefit from the price increases while maintaining low valuations, as well as those in sectors currently experiencing losses that may see price recovery [28].

Core Viewpoint - The article discusses the impact of geopolitical tensions in the Middle East and the closure of the Strait of Hormuz on the prices of various chemical raw materials, particularly vitamins and amino acids, leading to a significant tightening of supply and rising prices in the market [1]. Supply and Demand Analysis - The supply of vitamins and amino acids has been significantly tightened, with traders reporting that manufacturers are not shipping products, particularly popular varieties like Vitamin A and E [1]. - The current price surge has benefited producers and traders across the industry chain, although opinions on future price trends are divided [1]. Price Trends - The price increase for vitamins and amino acids began at the end of February and has continued for nearly a month, with various products experiencing different degrees of price rises [2]. - As of March 23, Vitamin E was priced at 89 RMB/kg, up 7.23% in the past week, while Vitamin A reached 101.71 RMB/kg, with a weekly increase of 15.96% [2]. - The price of imported methionine rose by 47.79% to 50.25 RMB/kg, and domestic methionine increased by 49.62% to 49 RMB/kg [2]. Inventory and Sales Dynamics - Traders have reported that their inventory has appreciated in value due to rising prices, with many holding back on sales to maximize profits [3]. - Despite the price increases, sales volumes have not shown significant changes compared to previous periods, with some traders indicating that demand is stable but not dramatically increasing [3][4]. Manufacturer Behavior - There are reports of manufacturers withholding stock, with many citing "force majeure" as a reason for halting supplies, leading to a situation where traders have limited access to products [4].

Summary of the Conference Call for Kingdawei Company and Industry Overview - **Company**: Kingdawei operates in the health supplement industry, uniquely covering the entire supply chain from raw materials to manufacturing and branding. [3] - **Market Position**: Kingdawei holds approximately 50% of the global market share for Coenzyme Q10 and has significant production capacity for Vitamins A and D. [3] Key Points and Arguments Financial Performance and Projections - **Revenue and Profit Growth**: Kingdawei expects revenue and profit growth rates between 10% and 20% in 2026, with a significant increase anticipated in 2028 as direct sales business is expected to explode. [2][14] - **Sales Performance**: The sales volume of Coenzyme Q10 is projected to increase by 10% to 15%, with a historical high in January 2026. [2][19] - **Doctor's Best Brand**: The brand's domestic GMV grew over 70% year-on-year in early 2026, exceeding market expectations. [2][17] - **Vitamin A Price Surge**: Due to geopolitical factors, Vitamin A prices increased by nearly 60% to 95 RMB/kg, potentially contributing an additional ten million RMB in profit. [2][20] Business Developments - **DHA Project**: The algae oil DHA project is ahead of schedule, expected to generate over 500 million RMB in annual revenue once fully operational, with an internal rate of return (IRR) exceeding 20%. [2][15] - **Zipfizz Brand Recovery**: The Zipfizz brand is anticipated to turn around in 2026 through new product launches and expansion via Costco channels. [2][18] Industry Dynamics - **Long-term Growth Drivers**: The health supplement industry is supported by an aging population and new consumption trends, with an expected annual growth rate of around 7% over the next three years. [6] - **E-commerce Role**: Cross-border e-commerce plays a crucial role, with nearly 60% of the Chinese health supplement market sales occurring online, half of which comes from cross-border e-commerce. [6] Additional Important Insights - **Production Capacity Expansion**: Kingdawei's production capacity for Coenzyme Q10 increased from 620 tons to 920 tons, which is expected to support future growth. [8][10] - **Market Demand for Coenzyme Q10**: The demand for Coenzyme Q10 is stable and expanding, with over 60% used in health supplements. [9][10] - **Vitamin A Market Characteristics**: The Vitamin A market is highly volatile, primarily driven by demand from feed additives and influenced by the pig cycle. Kingdawei acts as a price follower with limited bargaining power. [11][12] Conclusion Kingdawei is positioned for significant growth in the health supplement industry, with strong projections for revenue and profit increases driven by strategic brand management, production capacity expansion, and favorable market conditions. The company is also adapting to market dynamics and consumer trends, particularly through e-commerce channels.

Core Insights - The report highlights the investment opportunities in the pharmaceutical sector, particularly focusing on Tianjin Tianshi Co., Ltd. after the acquisition by China Resources Group, which is expected to drive long-term growth [5][6][9] - The report emphasizes the structural bull market trend in the A-share market, with a focus on the rising opportunities in the new energy sector due to elevated oil prices [11][12][13] - The transportation sector is experiencing shifts due to geopolitical tensions, with shipping routes being adjusted and new business models emerging in low-altitude economy and autonomous driving [21][22] Pharmaceutical Sector - Tianjin Tianshi reported a revenue of 8.236 billion yuan in 2025, a decrease of 3.08% year-on-year, while net profit attributable to shareholders was 1.105 billion yuan, an increase of 15.63% [5][6] - The company is focusing on innovation and has a robust pipeline with 31 projects under development, including 11 in cardiovascular and metabolic diseases [8] - The management has implemented a strategic plan aiming for a doubling of industrial revenue to 15 billion yuan by 2030, leveraging resources from China Resources [6][9] Energy Sector - The report notes that Brent crude oil prices have remained above $100, influenced by geopolitical conflicts, which underscores the importance of energy transition [13] - The new energy sector, including solar and wind power, is expected to perform well as it is less affected by geopolitical tensions compared to fossil fuels [13] - Investment opportunities in the new energy sector are highlighted, with various segments such as batteries and storage systems showing promising growth [13] Transportation Sector - The report discusses the impact of the geopolitical situation on shipping routes, with VLCCs rerouting to avoid disruptions in the Strait of Hormuz [21][22] - Air cargo capacity remains tight due to Middle Eastern tensions, leading to adjustments in flight schedules and routes by carriers [21][22] - The emergence of new business models in the low-altitude economy, including partnerships between tech companies and ride-sharing platforms, is noted as a significant trend [21][22]

Investment Rating - The report rates the chemical industry as "Outperforming the Market" [1] Core Views - International oil prices have risen, impacting the prices of methanol and methionine due to ongoing geopolitical conflicts affecting oil and some petrochemical product supplies and transportation [1] - The current P/E ratio for the SW basic chemical sector is 28.03, at the 81.52 percentile historically, while the P/B ratio is 2.53, at the 70.98 percentile historically [1] - The report anticipates that the current round of industry expansion is nearing its end, with measures like "anti-involution" expected to catalyze a recovery in industry profits [1] - The new materials sector is expected to benefit from rapid downstream demand growth, potentially initiating a new phase of high growth [1] Summary by Sections Industry Dynamics - As of March 22, 2026, the SW petrochemical sector's P/E ratio is 16.74, at the 50.60 percentile historically, and the P/B ratio is 1.62, at the 55.15 percentile historically [1] - The report highlights the need to focus on large energy state-owned enterprises, leading companies in coal chemical with stable and relatively low-cost raw material supply, and leading fine chemical companies with favorable supply-demand dynamics [1] Investment Recommendations - Short-term focus on large energy state-owned enterprises, coal chemical leaders, and fine chemical leaders with good cost transmission [1] - Long-term investment themes include traditional chemical leaders showing resilience, continuous improvement in supply-demand dynamics in sub-sectors like refining, polyester, dyes, organic silicon, pesticides, refrigerants, and phosphorous chemicals [1] - Recommended stocks include China Petroleum, China National Offshore Oil Corporation, China Petrochemical, Hengli Petrochemical, and others [1] Price Trends - For the week of March 16-22, 2026, 60 out of 100 tracked chemical products saw price increases, with notable rises in vitamin A, ethylene, naphtha, TDI, and methionine [28] - Methanol prices increased to 2,432 RMB/ton, up 7.04% week-on-week and 27.93% month-on-month [30] - Methionine prices rose to 39.5 RMB/kg, up 25.4% week-on-week and 111.23% month-on-month [31]

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - The chemical sector has experienced significant volatility, with the CITIC Basic Chemical Index dropping by 9.49% and the Shenwan Chemical Index falling by 10.53% this week [2][13] - The report highlights the impact of geopolitical tensions, particularly the Iranian attack on Qatar, which has affected 17% of Qatar's liquefied natural gas export capacity, leading to an estimated annual revenue loss of approximately $20 billion [3] - The commencement of the first phase of Hengyi's coal-to-chemical fiber project, with an investment of 25.7 billion yuan, is noted as a significant development in the industry [3] Summary by Sections Market Performance - The Shanghai Composite Index decreased by 3.38%, while the ChiNext Index increased by 1.26% [2][13] - The top five sub-industries in terms of performance were polyester (-4.83%), paint and ink (-5.56%), rubber products (-5.88%), tires (-6.29%), and other plastic products (-6.52%) [2][16] - The bottom five sub-industries included phosphate and phosphorus chemicals (-16.22%), chlor-alkali (-12.89%), pesticides (-12.08%), soda ash (-11.43%), and potassium fertilizer (-11.39%) [2][16] Major Industry Developments - The Iranian attack on Qatar has led to a significant disruption in LNG production, with two out of 14 production lines damaged, resulting in a production interruption of 12.8 million tons annually for 3 to 5 years [3] - Hengyi Group's coal-to-chemical fiber project in Turpan, Xinjiang, is set to invest 150 billion yuan over 5 to 8 years, aiming to create a vertically integrated industrial cluster [3] Investment Themes - The tire sector is highlighted as having strong domestic competitiveness, with recommended companies including Sailun Tire, Senqcia, General Tire, and Linglong Tire [3] - The consumer electronics sector is expected to gradually recover, with a focus on upstream material companies benefiting from the recovery in the panel industry [4] - The report suggests attention to resilient cyclical industries and those that have completed inventory destocking, which may outperform the broader market in the coming year [4] Sub-Industry Insights - In the polyurethane sector, pure MDI prices remained stable at 22,300 yuan/ton, with operating rates at 73.5% [27] - The tire industry shows a slight increase in operating rates for both all-steel and semi-steel tires, indicating a stable demand environment [51] - The agricultural chemicals sector is experiencing price increases for glyphosate and other pesticides, driven by supply constraints and rising raw material costs [53][56]

Investment Rating - The report maintains a "Positive" investment rating for the pharmaceutical and biotechnology industry [1] Core Insights - The animal health raw material drug prices are expected to experience a cyclical rebound in 2026 due to a recovery in industry demand and stabilization of antibiotic supply chain prices [1] - The heparin raw material drug industry is currently at a cyclical low, with prices declining sharply in 2023, but expected to stabilize by 2025 [2][56] - The vitamin industry is entering a price increase cycle influenced by geopolitical tensions and rising oil prices, leading to significant price increases for vitamin A and E [3][58] Summary by Sections Raw Material Prices and Trends - The PPI index for China's chemical raw materials has been on a downward trend, while upstream raw material prices are showing an upward trend, which may accelerate the supply clearance in the raw material drug industry [11][18] - Antibiotic prices, including 6-APA and penicillin industrial salt, are showing signs of recovery after hitting bottom [25][29] - The average price of florfenicol has dropped from 400-700 RMB/kg to 150-200 RMB/kg, indicating a significant decline due to oversupply and weak downstream demand [46][49] Investment Recommendations - The report suggests focusing on companies that have undergone thorough supply clearance and have expectations for price increases, recommending stocks such as Guobang Pharmaceutical, Puluo Pharmaceutical, and Aorite [4][72] - Beneficiary stocks include Meinuo Pharmaceutical, Chuaning Biological, and Zhejiang Pharmaceutical, among others [4][72] Price Trends in Specific Segments - Heparin API prices are expected to stabilize in 2025 after a period of decline due to oversupply [56][57] - Iodine raw material prices have seen a recovery due to strong demand from other industries, following a period of significant price increases [2][56] - The vitamin A and E prices are experiencing rapid increases due to geopolitical tensions affecting oil prices and supply chain disruptions [3][58]